Micreos initiates clinical trial to evaluate endolysin-drug in atopic dermatitis
The study marks the world’s first evaluation of a pharmaceutical endolysin for topical use in humans. Endolysins are highly specific enzymes that cut the bacterial cell wall, rapidly